House Reps Call For Balance In 510(k) Overhaul
As the U.S. Food and Drug Administration contemplates changes to the 510(k) approval pathway for medical devices, members of the U.S. House of Representatives are asking federal regulators to work closely...To view the full article, register now.
Already a subscriber? Click here to view full article